Akebia Therapeutics Inc AKBA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/24/21 EDT
2.92quote price arrow up+0.06 (+2.10%)
Volume
22,367
Close
2.86quote price arrow down-0.05 (-1.72%)
Volume
1,508,027
52 week range
2.09 - 5.14
Loading...
  • Open2.88
  • Day High2.94
  • Day Low2.84
  • Prev Close2.91
  • 52 Week High5.14
  • 52 Week High Date02/08/21
  • 52 Week Low2.09
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap499.18M
  • Shares Out174.54M
  • 10 Day Average Volume1.85M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change2.14

KEY STATS

  • Open2.88
  • Day High2.94
  • Day Low2.84
  • Prev Close2.91
  • 52 Week High5.14
  • 52 Week High Date02/08/21
  • 52 Week Low2.09
  • 52 Week Low Date10/30/20
  • Market Cap499.18M
  • Shares Out174.54M
  • 10 Day Average Volume1.85M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change2.14

RATIOS/PROFITABILITY

  • EPS (TTM)-1.98
  • P/E (TTM)-1.44
  • Fwd P/E (NTM)-2.38
  • EBITDA (MRQ)-254.397M
  • ROE (MRQ)-109.96%
  • Revenue (MRQ)221.90M
  • Gross Margin (MRQ)31.22%
  • Net Margin (MRQ)-135.00%
  • Debt To Equity (MRQ)55.50%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Akebia Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in developing vadadustat as an oral therapy. The Company's vadadustat is a HIF-prolyl-hydroxylase (HIF-PH) inhibitor in Phase III development for the...
Adrian Adams
Non-Executive Chairman
John Butler
President
Michel Dahan
Chief Operating Officer
David Spellman
Chief Financial Officer
Address
245 1st St
Cambridge, MA
02142-1200
United States

Top Peers

SYMBOLLASTCHG%CHG
OVID
Ovid Therapeutics Inc
3.45UNCHUNCH
PBYI
Puma Biotechnology Inc
6.82-0.02-0.29%
CLVS
Clovis Oncology Inc
4.67+0.06+1.30%
RIGL
Rigel Pharmaceuticals Inc
3.74-0.15-3.86%
CPRX
Catalyst Pharmaceuticals Inc
5.08+0.03+0.59%